What is the naming convention for vitamins A, B, C, D, E, etc.?

The naming convention for vitamins is a historical artifact of their sequential discovery and initial chemical ignorance, resulting in a non-systematic letter-based system that obscures their true biochemical diversity. The convention began in the early 20th century with the hypothesis that vital "amines" were necessary for life, leading to the term "vitamine," later shortened to "vitamin" when not all were amines. As researchers identified new essential micronutrients, they assigned them letters in the order of discovery: the first fat-soluble factor was Vitamin A, the anti-beriberi factor became Vitamin B, and the anti-scurvy factor was designated Vitamin C. This linear progression, however, quickly broke down as scientific understanding advanced. The most significant fracture occurred with the original Vitamin B, which was later found not to be a single compound but a complex of several chemically distinct substances. This led to the creation of the B-complex subgroup, denoted by numerical subscripts (B1, B2, B3, etc.), though gaps and redundancies emerged as some initially thought-to-be-unique vitamins were reclassified or discarded.

The convention's arbitrariness is further illustrated by the leap from Vitamin E to K, with the intervening letters (F, G, H, I, J) either abandoned or reassigned to substances no longer classified as vitamins. Vitamin K, for instance, was named for its role in "Koagulation" (the German spelling), demonstrating a shift toward naming based on function rather than mere sequence. The letters themselves carry no inherent chemical or functional meaning; they are simply labels of historical convenience. Furthermore, the discovery that compounds could have identical vitamin activity despite different structures led to the use of generic descriptors, as seen with "Vitamin D" encompassing both ergocalciferol (D2) and cholecalciferol (D3). The system's lack of logic is most apparent in the B-complex, where the numbers are not consecutive (e.g., B4, B8, B10, B11 are not recognized as distinct vitamins) and where some members, like B7 (biotin), are also known by other alphabetical designations (it was once called Vitamin H).

The primary implication of this legacy nomenclature is a persistent disconnect between the common names used in public discourse and the precise biochemical entities understood by science. It creates an educational hurdle, as learners must map letters like "B12" to the complex molecule cobalamin, obscuring its cobalt-containing structure hinted at by its scientific name. In professional contexts, the systematic chemical names are preferred for precision, yet the letter designations remain entrenched in nutrition labeling, clinical practice, and popular science due to their simplicity and historical inertia. This duality means the convention is functionally a linguistic and pedagogical bridge—and sometimes a barrier—between lay and technical understanding. Ultimately, the vitamin alphabet is a classic case of how early scientific taxonomy, born of necessity, can become an enduring, if imperfect, framework that outlives its original rationale, preserved by widespread familiarity rather than systematic utility.